Index. Anesthesiology Clin N Am 24 (2006) Note: Page numbers of article titles are in boldface type.

Transcription

1 Anesthesiology Clin N Am 24 (2006) Index Note: Page numbers of article titles are in boldface type. A Abdominal surgery, synbiotics for control of inflammation and infection in, 312 Adaptive immunity, effect on long-term outcome after anesthesia and surgery, Alzheimer s disease, interactions of volatile anesthetics with proteins associated with, Amyloid beta, in studies of interaction of volatile anesthetics Anesthesia, long-term patient safety after, , patient safety movement in, Closed Claims Study, 238 culture of safety, 236 improved education, 238 present and future initiatives, audible information signals, 240 automated information systems, 239 high reliability organizational theory, 239 office-based anesthesia and surgery, 239 public recognition of, 236 safety research, standards and guidelines, 237 stimulation, 239 technological improvements, 237 prevention of risks in surgery and, pharmacologic modulation of operative risk in patients with prevention of, Anesthesia Patient Safety Foundation, 236 Anesthetics, volatile, interactions of with neurodegenerative disease-associated proteins, Alzheimer s disease, animal studies, biophysical basis for interactions, biophysical mechanism of neurodegeneration, experimental evidence for interactions, halothane and isoflurane, /06/$ see front matter D 2006 Elsevier Inc. All rights reserved. doi: /s (06) anesthesiology.theclinics.com

2 420 INDEX human studies, Parkinson s disease, polyglutamic repeat diseases, 387 prion disorders, Aprotinin, reduction of operative risk with, in patients with cardiac disease, 376 Aspirin, lipid mediators triggered by, in resolution of inflammation, Audible information signals, improved anesthesia patient safety due to, 240 Automated information systems, improved anesthesia patient safety due to, 239 B Beta-adrenergic blockade, reduction of operative risk with, in patients with cardiac disease, Beta-blockers, effect on long-term outcome after anesthesia and surgery, 260 Bioecological control, of inflammation and infection in critical illness, future aspects of, hyperinflammation, immune dysfunction, immunoparesis, lactic acid bacteria, limited nutrition preserves immunity, 302 monitoring immunoparesis, prebiotics, probiotics, and synbiotics, for critically ill, 311 immediate treatment with, multistrain-multifiber, in surgical and ICU patients, premorbid health and outcome, preventing immunoparesis, reducing immunoparesis, role of HLA-DR, 305 Blood transfusions, long-term effect on patient safety, Brain function, monitoring during anesthesia, impact on patient safety, C C-reactive protein, effect on long-term outcome after anesthesia and surgery, Cardiac disease, pharmacologic modulation of operative risk in patients with, cardiac outcome, beta-adrenergic blockade, clonidine, statins, cognitive dysfunction after, aprotinin, 376 lidocaine, Cholinergic activity, and inflammatory reflex, linking stress to inflammation, Clonidine, effect on long-term outcome after anesthesia and surgery, 261 reduction of operative risk with, in patients with cardiac disease, Closed Claims Study, 238 Coagulation, linking stress to inflammation, Cognitive dysfunction, after cardiac surgery, Complications, postoperative, long-term effect on patient safety, Critically ill patients, bioecological control of inflammation and infection in, Cytokines, linking stress to inflammation, D Diabetes, impact of glucose control on risk of surgical site wound infections, E Education, medical, improved anesthesia patient safety due to improvements in, 238 Eicosanoids, switching classes of, in resolution of inflammation, G Glucose control, impact on risk of surgical site wound infections, H Halothane, interaction High Reliability Organizational theory, improved anesthesia patient safety due to, 239

3 INDEX 421 HLA-DR, role in immunoparesis, 305 Hypercapnia, as potential intervention to reduce risk of surgical wound infections, Hyperinflammation, Hypothermia, maintenance of normothermia to prevent surgical site wound infections, I Immune dysfunction, causes of, Immune response, intrinsic modifiers of, and long-term outcome after anesthesia and surgery, Immunoparesis, after surgery, monitoring, prevention of, reducing, role of HLA-DR in, 305 Immunosuppression, effect on long-term outcome after anesthesia and surgery, Infection, bioecological control of inflammation and, in critical illness, future aspects of, hyperinflammation, immune dysfunction, immunoparesis, lactic acid bacteria, limited nutrition preserves immunity, 302 monitoring immunoparesis, prebiotics, probiotics, and synbiotics, for critically ill, 311 immediate treatment with, multistrain-multifiber, in surgical and ICU patients, premorbid health and outcome, preventing immunoparesis, reducing immunoparesis, role of HLA-DR, 305 of surgical wounds, nonpharmacologic prevention of, background, glucose control, maintaining normothermia, potential interventions, hypercapnia, pain relief, 291 vascular volume, smoking, 289 supplemental oxygen, surgical site preparation, Inflammation, and innate immunity, effect on long-term outcome after anesthesia and surgery, bioecological control of infection and, in critical illness, future aspects of, hyperinflammation, immune dysfunction, immunoparesis, lactic acid bacteria, limited nutrition preserves immunity, 302 monitoring immunoparesis, prebiotics, probiotics, and synbiotics, for critically ill, 311 immediate treatment with, multistrain-multifiber, in surgical and ICU patients, premorbid health and outcome, preventing immunoparesis, reducing immunoparesis, role of HLA-DR, 305 cholinergic activity and, coagulation and, cytokines and, immune cells and inflammatory reflex, psychosocial stress and, transcription factors and, vasocoagulation and, 332 resolution of, alpha signaling omega, aspiring-triggered lipid mediators, resolvins and protectins, S D series resolvins, R E series and 17R D series resolvins,

4 422 INDEX endogenous anti-inflammation and pro-resolving pathways, in disease models, spontaneous resolution milieu for identification of, use of polyunsaturated fatty acids, when to resolve, Inflammatory disorders, examples of, 257 Inflammatory reflex, linking stress to inflammation, Information systems, automated, improved anesthesia patient safety due to, 239 Insulin therapy, effect on long-term outcome after anesthesia and surgery, 262 Interleukin-6, effect on long-term outcome after anesthesia and surgery, Intraoperative monitoring, impact on patient safety, brain function monitoring, historical perspective, professional liability effects on, Isoflurane, interaction L Lactic acid bacteria, prevention of neutrophil infiltration and tissue destruction in, Liability, professional, impact on patient anesthesia monitoring, Lidocaine, reduction of operative risk with, in patients with cardiac disease, Liver disease, chronic, synbiotics for control of inflammation and infection in, 313 Liver transplantation, synbiotics for control of inflammation and infection in, 313 Lungs, immunoparesis in, M Microbes, in endogenous anti-inflammation and pro-resolving biosynthetic pathways, Monitoring, intraoperative, impact on patient safety, brain function monitoring, historical perspective, professional liability effects on, N National Surgical Quality Improvement Program, feedback of comparative data, 242 in the private sector, other improvements through observational studies, 242 Neurodegeneration, common biophysical mechanism of, Neurodegenerative diseases, interactions of volatile anesthetics with proteins associated with, Alzheimer s disease, animal studies, biophysical basis for interactions, biophysical mechanism of neurodegeneration, experimental evidence for interactions, halothane and isoflurane, human studies, Parkinson s disease, polyglutamic repeat diseases, 387 prion disorders, Normothermia, maintenance of, in prevention of surgical site wound infections, Nutrition, limited, to preserve immunity after surgery or trauma, 302 O Office-based procedures, improved anesthesia patient safety in, 239 Outcome, long-term, after anesthesia and surgery, ,

5 INDEX 423 Oxygen, supplemental, in prevention of surgical site wound infections, P Pain relief, as potential intervention to reduce risk of surgical wound infections, 291 Pancreatitis, acute, synbiotics for control of inflammation and infection in, Parkinson s disease, interactions of volatile anesthetics with proteins associated with, Patient safety. See Safety, patient. Pheochromocytoma-12, interaction of volatile anesthetics Polyglutamine repeat diseases, interactions of volatile anesthetics with proteins associated with, 387 Polyunsaturated fatty acids, use during resolution of acute inflammation, Prebiotics, for control of inflammation and infection in critical illness, 309 Preparation, of surgical site, in prevention of surgical wound infections, Prevention, of risks in anesthesia and surgery, pharmacologic modulation of operative risk in patients with prevention of, Prion disorders, interactions of volatile anesthetics with proteins associated with, Probiotics, for control of inflammation and infection in critical illness, Professional liability, impact on patient anesthesia monitoring, Protectins. See Resolvins. Proteins, neurodegenerative disease-associated, interaction with volatile anesthetics, Psychosocial stress. See Stress. R Research, on anesthesia safety, Resolvins, and protectins in resolution of inflammation, S D series resolvins, R E series and 17R D series resolvins, alpha signaling omega, aspiring-triggered lipid mediators, endogenous anti-inflammation and pro-resolving pathways, in disease models, spontaneous resolution milieu for identification of, use of polyunsaturated fatty acids, when to resolve, Risk prevention, in anesthesia and surgery, pharmacologic modulation of operative risk in patients with prevention of,

6 424 INDEX S Safety, patient, impact of intraoperative monitoring on, brain function monitoring, historical perspective, professional liability effects on, in surgery, National Surgical Quality Improvement Program, feedback of comparative data, 242 in the private sector, other improvements through observational studies, 242 what have we learned, long-term outcome, after anesthesia and surgery, , movement for, in anesthesia, Closed Claims Study, 238 culture of safety, 236 improved education, 238 present and future initiatives, audible information signals, 240 automated information systems, 239 high reliability organizational theory, 239 office-based anesthesia and surgery, 239 public recognition of, 236 safety research, standards and guidelines, 237 stimulation, 239 technological improvements, 237 Smoking, increased risk of surgical site wound infections due to, 289 Statins, effect on long-term outcome after anesthesia and surgery, 261 reduction of operative risk with, in patients with cardiac disease, Stimulation, patient, improved anesthesia safety due to, 239 Stress, linking to inflammation, cholinergic activity and, coagulation and, cytokines and, immune cells and inflammatory reflex, psychosocial stress and, transcription factors and, vasocoagulation and, 332 Supplemental oxygen, in prevention of surgical site wound infections, Surgery, improved patient safety in, National Surgical Quality Improvement Program, feedback of comparative data, 242 in the private sector, other improvements through observational studies, 242 what have we learned, long-term outcome after anesthesia and, , nonpharmacologic prevention of surgical wound infection, background, glucose control, maintaining normothermia, potential interventions, hypercapnia, pain relief, 291 vascular volume,

7 INDEX 425 smoking, 289 supplemental oxygen, surgical site preparation, prevention of risks in anesthesia and, pharmacologic modulation of operative risk in patients with prevention of, Surgical site wounds. See Wounds, surgical site. Sympathoadrenergic cell activation, linking stress to inflammation, Synbiotics, for control of inflammation and infection in critical illness, multistrain-multifiber, in surgical and ICU patients, abdominal surgery, 312 acute pancreatitis, chronic liver disease and liver transplantation, 313 polytrauma, 312 specific formulas, 311 T Tau, in studies of interaction of volatile anesthetics Transcription factors, linking stress to inflammation, Transfusions, blood, long-term effect on patient safety, Trauma, multiple, synbiotics for control of inflammation and infection in, V Vascular volume, potential intervention to reduce risk of surgical wound infections, Vasoconstriction, linking stress to hypertension, 332 Volatile anesthetics. See Anesthetics, volatile. Volume, vascular, potential intervention to reduce risk of surgical wound infections, W Wounds, surgical site, infection of, nonpharmacologic prevention of, background, glucose control, maintaining normothermia, potential interventions, hypercapnia, pain relief, 291 vascular volume, smoking, 289 supplemental oxygen, surgical site preparation,